Amicus Therapeutics France SAS clinical trials
Acquired by BioMarin Pharmaceutical, Apr 27, 2026 · source ↗
The registry lists 2 studies whose lead sponsor is Amicus Therapeutics France SAS. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 23, 2024.
Before and after it joined BioMarin Pharmaceutical
- First submitted before Amicus Therapeutics France SAS became part of BioMarin Pharmaceutical
- 2
- First submitted after Amicus Therapeutics France SAS became part of BioMarin Pharmaceutical
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Amicus Therapeutics France SAS2 studies
Something wrong with this grouping? Tell us on the BioMarin Pharmaceutical page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All BioMarin Pharmaceutical studies →
- Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and PreferencesCompletedNCT04043273
Sponsor listed in the registry: Amicus Therapeutics France SAS · First submitted before Amicus Therapeutics France SAS became part of BioMarin Pharmaceutical
- French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With MigalastatCompletedNCT04602364
Sponsor listed in the registry: Amicus Therapeutics France SAS · First submitted before Amicus Therapeutics France SAS became part of BioMarin Pharmaceutical